首页> 外国专利> Methods for purging ex vivo cells in autologous transplant, for the preparation of collected cells substantially free of malignant cells, collected cells, and a method for autologous transplant of cells.

Methods for purging ex vivo cells in autologous transplant, for the preparation of collected cells substantially free of malignant cells, collected cells, and a method for autologous transplant of cells.

机译:用于在自体移植中清除离体细胞的方法,用于制备基本上不含恶性细胞的收集细胞,所收集的细胞以及用于细胞自体移植的方法。

摘要

Methods for purging ex vivo cells in autologous transplant, for the preparation of collected cells substantially free of malignant cells, collected cells, and a method for autologous transplant of cells.The present invention relates to a method for purging ex vivo cells in autologous transplant, in which the sample of collected cells is treated with a sufficient amount of a multimu00e9rica of soluble portion of FasL to kill the malignant cells without substantially affecting the VI Ability of cells to be transplanted.Autologous transplantation of stem cells (ASCT) after high-dose chemotherapy with or without radiotherapy became the standard therapy for most patients with large cell lymphomas, multiple myeloma, and Hodgkin's disease refractory / relapsed.This therapy is now also considered for selected patients lymphoma type low (chronic lymphocytic leukemia, follicular lymphoma, mantle cell lymphoma of) and for patients with acute myeloid leukemia (AML). The current treatments for purging of cells include chemotherapy and cocktail of antibodies.These treatments are often toxic to stem cells and not efficient in eliminating cancer cells. Thus, there is a medical need not answered for purging of cells in ASCT which this designs will be addressed.
机译:自体移植中离体细胞的清除方法,制备的基本上不含恶性细胞的收集细胞,收集的细胞和细胞自体移植的方法。本发明涉及自体移植中离体细胞的清除方法,用足够量的FasL可溶性部分的多倍数处理收集的细胞样品以杀死恶性细胞,而基本上不影响待移植细胞的VI能力。大剂量淋巴瘤,多发性骨髓瘤和霍奇金病难治性/复发的大多数患者,大剂量化疗加或不加化疗已成为标准疗法。对于某些类型的低淋巴瘤(慢性淋巴细胞性白血病,滤泡性淋巴瘤,的套细胞淋巴瘤和急性髓细胞性白血病(AML)患者。目前用于清除细胞的方法包括化学疗法和抗体混合物,这些方法通常对干细胞有毒且不能有效消除癌细胞。因此,对于该设计将解决的在ASCT中清除细胞的医学需求没有得到满足。

著录项

  • 公开/公告号BRPI0516723A

    专利类型

  • 公开/公告日2008-09-16

    原文格式PDF

  • 申请/专利权人 APOXIS SA;

    申请/专利号BR2005PI16723

  • 发明设计人 MARC DUPUIS;PETER GREANEY;MICHEL DUCHOSAL;

    申请日2005-09-30

  • 分类号C12N5/16;

  • 国家 BR

  • 入库时间 2022-08-21 20:08:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号